Exec Chat: CHF Solutions Focused On Expanding Access To Aquadex Ultrafiltration
Nestor Jaramillo, who just finished his first quarter as CEO of CHF Solutions, told Medtech Insight how his company is making its Aquadex ultrafiltration technology part of the standard of care for heart failure patients and others with dangerous fluid overload.
You may also be interested in...
The company has switched from pursuing a counterpulsation technology to focusing on a fully implantable neuromodulation device, and is now directing its full attention to the recently acquired Aquadex FlexFlow ultrafiltration system for heart failure, all in a period of about three-to-four months.
The Minnesota-based health care system announced the formation of Anumana Inc. to commercialize artificial intelligence-enabled algorithms and Lucem Health to curate data collected from remote monitoring devices.
In this week’s podcast, Medtech Insight managing editor Marion Webb discusses plans by the Mayo Clinic and Veterans Health Administration to position themselves as medical device makers of 3D-printing technologies. UK-based reporter Barnaby Pickering gives an overview of global market for arthroscopy and sports medicine products.